India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q1 FY26 Earnings Presentation
41 slides from India Glycols's earnings presentation, Aug 11, 2025
Slide 1: Stock exchange covering letter for updated investor presentation
IGL/SE/2025-26/34 11th August, 2025 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 001 Mumbai- 4
Slide 2: Investor Presentation Q1 FY26
Investor Presentation Q1 FY26
Slide 3: Safe Harbor Statement
Safe Harbor Statement This presentation and the following discussion may contain “forward looking statements” by India Glycols Limited (“IGL” or the company) that are not historical in nature. These forward-looking statements, which may include statements relating to future results of operations, fi
Slide 4: Table of Contents
Table of Contents 01 Q1FY26 Financial Highlights 02 Q1FY26 Segmental Highlights 03 Proposed Restructuring 04 Business Overview 05 Annual Financial Highlights 06 Annexures
Slide 5: Q1FY26 Financial Highlights
Q1FY26 Financial Highlights
Slide 6: Q1FY26 Performance Overview
Q1FY26 Performance Overview Figures in ₹ Cr. Gross Revenue Net Revenue EBITDA & EBITDA Margin PAT & PAT Margin +10% 13.2% 14.5% 6.2% 7.0% 2,503 2,283 7% +18% +21% 969 1,040 151 128 60 73 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 ⦁ Strong Performance for the quarter with Net Revenue up
Slide 7: Highlights – Q1FY26
Highlights – Q1FY26 Figures in ₹ Cr. Business Performance | Q1FY26 over Q1FY25 Net Revenue stood at ₹ 1,040 Cr in Q1FY26 vs. ₹ 969 Cr in Q1FY25, up by 7.4% – Bio Fuel increased by 45.4% to ₹ 348 Cr – PS up by 22.4% YoY to ₹ 342 Cr – EB stood ₹ 51 Cr – BSPC stood at ₹ 300 Cr EBITDA increased by 1
Slide 8: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 Y-o-Y (%) FY25 FY24 Y-o-Y (%) Gross Revenue from Operations 2,503 2,283 9.7% 9,039 7,922 14.1% Revenue from Operations (Net of excise) 1,040 969 7.4% 3,768 3,294 14.4% Other Income 1 3 15 26 Total Income 1,042 971 7.2% 3,783
Slide 9: Financial Summary - Standalone
Financial Summary - Standalone Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 Y-o-Y (%) FY25 FY24 Y-o-Y (%) Gross Revenue from Operations 2,503 2,282 9.7% 9,038 7,919 14.1% Revenue from Operations (Net of Excise) 1,040 968 7.4% 3,767 3,291 14.5% Other Income 1 3 15 26 Total Income 1,042 971 7.3% 3,782 3
Slide 10: Highlights – Q1FY26 Other Highlights
Highlights – Q1FY26 Other Highlights Continued solid performance in CL with Bunty Bubli again being recognized as the “Highest Selling Brand”. Market share increased in UK, while a close leadership position continues to be upheld in UP. Amrut Partnership is gaining momentum in UP,UK and Delhi, w
Slide 11: Q1FY26 Segmental Highlights
Q1FY26 Segmental Highlights
Slide 12: Segmental Highlights – Q1FY26
Segmental Highlights – Q1FY26 Net Revenue and EBIT Margin (%) Figures in ₹ Cr. Bio-Based Specialties and Potable Spirits (PS) Performance Chemicals (BSPC) 700 9.9% 10.9% 500 450 17.5% 21.1% 600 400 500 350 300 400 250 342 300 200 393 280 150 300 200 100 100 50 - - Q1FY25 Q1FY26 Q1FY25 Q1FY26 Bio-Fue
Slide 13: Segmental Revenue and EBIT Mix – Consolidated – Q1FY26
Segmental Revenue and EBIT Mix – Consolidated – Q1FY26 Revenue Mix EBIT Mix 1% 5% 6% 25% 6% 34% 33% 29% 29% 40% 43% 56% 18% 33% 25% 17% Q1FY26 Q1FY25 Q1FY26 Q1FY25 BSPC Bio-Fuel PS EB Consolidated Financials 12 12
Slide 14: Segment Performance – BSPC
Segment Performance – BSPC Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 % YoY Q4FY25 % QoQ Bio-based Specialities and Performance Chemicals (BSPC) Net Revenue 300 393 (23.7%) 254 18.0% EBIT 33 39 (16.0%) 29 12.2% % margin 10.9% 9.9% 100 bps 11.4% (56 bps) BSPC achieved ₹ 300 Cr revenue with EBIT of
Slide 15: Segment Performance - PS
Segment Performance - PS Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 % YoY Q4FY25 % QoQ Portable Spirits (PS) Net Revenue 342 280 22.4% 284 20.6% EBIT 72 49 47.4% 78 (7.8%) % margin 21.1% 17.5% 358 bps 27.6% (649 bps) PS delivered ₹ 342 Cr revenue, up 22.4% YoY, EBIT of ₹ 72 Cr, up 47.4% YoY; margi
Slide 16: Segment Performance – Bio-Fuel
Segment Performance – Bio-Fuel Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 % YoY Q4FY25 % QoQ Bio Fuel Net Revenue 348 239 45.4% 273 27.1% EBIT 23 19 21.4% 16 42.6% % margin 6.5% 7.8% (129 bps) 5.8% 71 bps Bio Fuel delivered ₹ 348 Cr revenue up by 45.4% YoY with EBIT of ₹ 23 Cr, up by +21.4% YoY; m
Slide 17: Segment Performance - EB
Segment Performance - EB Figures in ₹ Cr. Particulars Q1FY26 Q1FY25 % YoY Q4FY25 % QoQ Ennature Biopharma (EB) Net Revenue 51 57 (11.1%) 52 (2.0%) EBIT 1 6 (81.4%) 4 (72.0%) % margin 2.4% 11.4% (898 bps) 8.3% (595 bps) EB delivered ₹ 51 Cr revenue vs ₹ 57 Cr in Q1FY25 with 2.4% EBIT margin Despi
Slide 18: Proposed Restructuring
OS Proposed Restructuring
Slide 19: Revised Proposed Scheme and Structure
Revised Proposed Scheme and Structure Management of IGL to enter Promoter Group into a composite scheme of 95.78% arrangement for the following: Kashipur Holdings Demerger of Potable Spirits & Bio- Limited (KHL) fuel and Bio-pharma Businesses – KHL currently holds respective businesses to be 50.35
Slide 20: Proposed Business Structure (FY 2024-25)
Proposed Business Structure (FY 2024-25) Figures in ₹ Cr. Existing Structure Bio-based Specialties and Potable Spirits Ennature Biopharma Bio-Fuel Performance Chemicals Glycols, Glycol Ethers New IMFL Bio Pharma Bio-Fuel Country Liquor Specialties, Bio Polymers, ENA, Gases ₹ 1,341 Cr ₹ 1,044 Cr ₹ 6,
Slide 21: Benefits of the Proposed Scheme
Benefits of the Proposed Scheme Each business will have a Will create a potential to Each business will manage its clear focus, leading to unlock value for capital, investments, and improved management stakeholders by drawing resources based on its specific and resource allocation focused investors
Slide 22: Business Overview
4. Business Overview
Slide 23: Company at a Glance
Company at a Glance Business Overview India Glycols Limited (IGL), founded in 1983, is one of the leading manufacturer of Bio-based Specialties & Performance Chemicals (BSPC), Bio- Fuel, Potable Spirits (PS) and Ennature Biopharma (EB). It is the first company in the world to produce Ethylene Oxide
Slide 24: Key Strengths
Key Strengths 3+ decades of presence 3x3 strategy for Cost Effectiveness Diversified business model and R&D: Creating value with focus applications on Green Chemistry & Technical collaborations India’s leading Green Chemical Strong Management Team Company Integrated Manufacturing facilities – Financ
Slide 25: IGL Journey of more than 3 decades
IGL Journey of more than 3 decades 1983-2000 2001 - 2007 2008-2014 2015-2022 2023-2025 1983: Incorporation as UP 2001: Starting of glycol 2008: Expansion of MEG 2015: Bio-polymers 2023: Sale of entire stake in Glycols Ltd ether plant and gaur gum plant and commissioning expansion Shakumbari Sugar an
Slide 26: Diversified business model and multi-functional application
Diversified business model and multi-functional application Business segments Applications Bio-based Specialities and Performance Chemicals (BSPC) Potable Spirits (PS) Automotive Bio Glycols: Bio Mono Ethylene Glycol, Bio Di Ethylene Glycol, etc. License for operations and sale of Country Liquor
Slide 27: India’s leading Green Chemical Company
India’s leading Green Chemical Company Green is in IGL’s DNA and is the core of our business: Inspired by nature and Green chemistry, we create compounds based on decades of expertise, innovative engineering and sustainable technologies, while ensuring our environment remains untouched. Only manufac
Slide 28: Capabilities
Integrated Manufacturing facilities Kashipur Gorakhpur Dehradun 300-acre state 56-acre state of of art integrated art distillation & 1,60,000 sqft state manufacturing bottling complex of art facility complex Fermentation – Molasses and Grain Based Grain based Ethanol High Purity Extraction E
Slide 29: Leveraging synergies to create value–integrated manufacturing
Leveraging synergies to create value–integrated manufacturing for bio-based products Portable Spirits (PS) Products Potable Power Industrial ENA O2, N2, Ar Spirit Brands Alcohol Gas Division Ind Gr. CO2 Grain O2 ASU EO-CO2 mix Business transferred to JV with Clariant Bio-based Specialities Green And
Slide 30: 3 x 3 Strategy for Cost Effectiveness
3 x 3 Strategy for Cost Effectiveness Mitigating costs with 3 possible 3 possible sources of raw material outputs Imported Bio-based Ethanol Chemicals Domestically Bio-fuels bought Ethanol In-house Potable Ethanol Spirits Ethanol plants capacities (including grain-based) of 600 KLPD and 500 KLPD a
Slide 31: R&D: Creating value through focus on Green Chemistry
R&D: Creating value through focus on Green Chemistry with Technical collaborations IGL pioneers’ sustainable trends with innovative, technology-driven solutions that reduce carbon footprints, leveraging digital technologies to reach net zero emissions and lead the way in green innovation. The state-
Slide 32: Growth Drivers
Growth Drivers High prospects of growth of Increasing consumer Companies taking steps to Growing demand for natural IGL is ideally placed to seize industry sectors being awareness and demand for significantly decrease carbon and safer products in the opportunity arising out serviced by IGL – Persona
Slide 33: Annual Financial Overview
4 Annual Financial Overview
Slide 34: 3-year Financial Trajectory - Consolidated
3-year Financial Trajectory - Consolidated Figures in ₹ Cr. Gross Revenue Net Revenue 9,039 3,768 7,922 3,294 6,642 2,651 FY23 FY24 FY25 FY23 FY24 FY25 EBITDA & EBITDA Margin (%) Adj. PAT* & Adj. PAT Margin (%) 11.9% 12.9% 13.9% 5.3% 5.2% 6.1% 525 231 428 319 173 141 FY23 FY24 FY25 FY23 FY24 FY25 *
Slide 35: 3-year Key Ratios - Consolidated
3-year Key Ratios - Consolidated Return on Capital Employed (%) Debt-to-Equity Ratio (x) 11.6% 0.80 10.5% 0.64 0.58 7.7% FY23 FY24 FY25 FY23 FY24 FY25 Cash Conversion Cycle* (Days) Interest Coverage Ratio (x) 64 59 43 2.71 2.50 2.26 FY23 FY24 FY25 FY23 FY24 FY25 * Cash Conversion Cyle = Debtor Days
Slide 36: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Particulars (In ₹ Cr) FY23 FY24 FY25 FY23-25 CAGR Gross Revenue from operations 6,642 7,922 9,039 16.7% Revenue from operations (Net of excise) 2,651 3,294 3,768 19.2% Other Income 24 26 15 Total Income 2,675 3,320 3,783 18.9% EBITDA 319 428 525 28.3
Slide 37: Financial Summary - Consolidated
Financial Summary - Consolidated Figures in ₹ Cr. Balance Sheet Cash Flow Statement Particulars (₹ Cr.) (as at end of) FY23 FY24 FY25 Particulars (₹ Mn) FY23 FY24 FY25 Fixed Assets 2,690 3,171 3,736 Cash and Cash Equivalents (Opening Balance) 7 2 27 CWIP 125 84 98 Investment 318 335 381 Cash Flow fr
Slide 38: Annexures
05 Annexures oe"
Slide 39: Shareholder’s Information
Shareholder’s Information Shareholding Pattern Shareholder Information as on 30th June 2025 Public & BSE Ticker 500201 Others, 30.77% NSE Symbol INDIAGLYCO Market Cap (in ₹ Cr.) 6,387.67 % Free- float 38.99% Bodies as on Corporates, 30 June 2025 th Free Float Market Cap (in ₹ Cr.) 2,490.55 3.39% Sha
Slide 40: Sustainability, ESG
Sustainability, ESG Social Environment Adherence to high safety and operational standards for handling hazardous materials. Employee and worker training for skill development. Implementation of preventive measures to Governance Utilization of briquettes made from plant Stakeholder engageme
Slide 41: India Glycols Limited CIN: L24111UR1983PLC009097
India Glycols Limited Head office Ernst & Young LLP 2B, Sector-126, Noida CIN: Gautam Budh Nagar Rohit Anand L24111UR1983PLC009097 Uttar Pradesh 201304 rohit.anand4@in.ey.com Ankur Jain Tel: +91-120-6860000, 3090100, 3090200 Riddhant Kapur Company Secretary & Fax: +91-120-3090111 Riddhant.kapur@in.e